DE60326320D1 - Zusammensetzung zur inhalation - Google Patents
Zusammensetzung zur inhalationInfo
- Publication number
- DE60326320D1 DE60326320D1 DE60326320T DE60326320T DE60326320D1 DE 60326320 D1 DE60326320 D1 DE 60326320D1 DE 60326320 T DE60326320 T DE 60326320T DE 60326320 T DE60326320 T DE 60326320T DE 60326320 D1 DE60326320 D1 DE 60326320D1
- Authority
- DE
- Germany
- Prior art keywords
- inhalation
- composition
- formoterol
- budesonide
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940021598 formoterol and budesonide Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Networks Using Active Elements (AREA)
- Pyrane Compounds (AREA)
- Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200312A SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Novel composition |
| PCT/SE2003/000156 WO2003063842A1 (en) | 2002-02-01 | 2003-01-29 | Composition for inhalation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60326320D1 true DE60326320D1 (de) | 2009-04-09 |
Family
ID=20286853
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60326320T Expired - Lifetime DE60326320D1 (de) | 2002-02-01 | 2003-01-29 | Zusammensetzung zur inhalation |
| DE60332067T Expired - Lifetime DE60332067D1 (de) | 2002-02-01 | 2003-01-29 | Neuartige Zusammensetzung |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60332067T Expired - Lifetime DE60332067D1 (de) | 2002-02-01 | 2003-01-29 | Neuartige Zusammensetzung |
Country Status (27)
| Country | Link |
|---|---|
| US (8) | US7759328B2 (enExample) |
| EP (2) | EP1474117B1 (enExample) |
| JP (2) | JP2005521663A (enExample) |
| KR (2) | KR100947168B1 (enExample) |
| CN (1) | CN1287774C (enExample) |
| AT (2) | ATE423552T1 (enExample) |
| AU (1) | AU2003206289B2 (enExample) |
| BR (1) | BR0307193A (enExample) |
| CA (1) | CA2474479C (enExample) |
| CO (1) | CO5611098A2 (enExample) |
| CY (2) | CY1109030T1 (enExample) |
| DE (2) | DE60326320D1 (enExample) |
| DK (2) | DK1474117T3 (enExample) |
| ES (2) | ES2321180T3 (enExample) |
| IL (1) | IL163160A (enExample) |
| IS (2) | IS7360A (enExample) |
| MX (1) | MXPA04007295A (enExample) |
| NO (1) | NO337006B1 (enExample) |
| NZ (1) | NZ534452A (enExample) |
| PL (1) | PL211836B1 (enExample) |
| PT (2) | PT2036549E (enExample) |
| RU (1) | RU2301673C2 (enExample) |
| SE (1) | SE0200312D0 (enExample) |
| SI (2) | SI2036549T1 (enExample) |
| UA (1) | UA79445C2 (enExample) |
| WO (1) | WO2003063842A1 (enExample) |
| ZA (1) | ZA200406086B (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
| BRPI0606736A2 (pt) * | 2005-02-11 | 2009-07-21 | Argenta Discovery Ltd | combinação de compostos e esteróides de metilxantina para tratar doenças respiratórias crÈnicas |
| US9084799B2 (en) | 2005-02-11 | 2015-07-21 | Pulmagen Therapeutics (Synergy) Limited | Inhaled combination therapy |
| DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
| GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
| GB0712454D0 (en) * | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US20130160761A1 (en) * | 2008-11-04 | 2013-06-27 | Cipla Limited | Pharmaceutical Aerosol Composition |
| NZ574666A (en) * | 2009-02-05 | 2009-04-30 | Nexus6 Ltd | A medicament inhaler holder that uses optical means to count and display the number of doses used |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| US9265910B2 (en) | 2009-05-18 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Adapter, inhalation device, and nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| AP3141A (en) | 2009-11-25 | 2015-02-28 | Boehringer Ingelheim Int | Nebulizer |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| CN105412122A (zh) | 2010-07-16 | 2016-03-23 | 希普拉有限公司 | 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物 |
| WO2012016845A2 (en) * | 2010-08-03 | 2012-02-09 | Chiesi Farmaceutici S.P.A. | Pharmaceutical formulation comprising a phosphodiesterase inhibitor |
| EP2618816A4 (en) * | 2010-09-22 | 2014-10-29 | Map Pharmaceuticals Ltd | AEROSOL COMPOSITION FOR THE ADMINISTRATION OF MEDICAMENTS |
| US20120204871A1 (en) | 2011-02-10 | 2012-08-16 | Julio Cesar Vega | Stable, non-corrosive formulations for pressurized metered dose inhalers |
| TWI399202B (zh) * | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| MY171271A (en) | 2011-08-19 | 2019-10-07 | Intech Biopharm Ltd | Method for preparing metered dose sprayed inhaler for treating respiratory disease |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| GB201321712D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| GB201321717D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Inhalable Medicaments |
| CN106456913B (zh) | 2014-05-07 | 2019-08-30 | 勃林格殷格翰国际有限公司 | 喷雾器和容器 |
| DK3139979T3 (da) | 2014-05-07 | 2023-10-09 | Boehringer Ingelheim Int | Enhed, forstøver og fremgangsmåde |
| EP3139984B1 (en) | 2014-05-07 | 2021-04-28 | Boehringer Ingelheim International GmbH | Nebulizer |
| WO2016018892A1 (en) * | 2014-07-29 | 2016-02-04 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
| ES2796177T5 (es) | 2015-12-04 | 2024-10-29 | Mexichem Fluor Sa De Cv | Composición farmacéutica |
| CN106581010B (zh) * | 2016-12-28 | 2019-03-05 | 四川普锐特医药科技有限责任公司 | 一种气溶胶制剂及定量吸入气雾剂 |
| CA3073195A1 (en) | 2017-08-15 | 2019-02-21 | Nephron Pharmaceuticals Corporation | Aqueous nebulization composition |
| JP7470646B2 (ja) | 2018-06-14 | 2024-04-18 | アストラゼネカ・ユーケイ・リミテッド | コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法 |
| JP7402631B2 (ja) | 2018-08-27 | 2023-12-21 | 帝人株式会社 | 極細炭素繊維混合物、その製造方法、及び炭素系導電助剤 |
| CN109464429B (zh) * | 2018-12-13 | 2021-04-27 | 上海方予健康医药科技有限公司 | 一种吸入压力定量气雾剂药物组合物及其制备方法 |
| CN112137957B (zh) | 2019-06-26 | 2022-07-29 | 长风药业股份有限公司 | 一种药用吸入气雾剂及其制备方法 |
| CN112972384B (zh) * | 2019-12-02 | 2022-03-18 | 长风药业股份有限公司 | 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法 |
| CN117357485B (zh) * | 2023-11-01 | 2024-09-24 | 山东京卫制药有限公司 | 一种改良的可吸入的载体颗粒及应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL103238A (en) * | 1991-09-25 | 1995-07-31 | Fisons Plc | Pressurised aerosol compositions |
| US6123924A (en) * | 1991-09-25 | 2000-09-26 | Fisons Plc | Pressurized aerosol inhalation compositions |
| WO1993011773A1 (en) | 1991-12-18 | 1993-06-24 | Aktiebolaget Astra | New combination of formoterol and budesonide |
| DE19536902A1 (de) * | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| SE9603669D0 (sv) | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
| EP0938467B1 (en) | 1996-11-11 | 2002-06-12 | Sepracor, Inc. | Process for the preparation of optically pure isomers of formoterol |
| SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| ATE283033T1 (de) | 1998-07-24 | 2004-12-15 | Jago Res Ag | Medizinische aerosolformulierungen |
| US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| SE9900834D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0009584D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
| GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| GB0016876D0 (en) * | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
| US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
-
2002
- 2002-02-01 SE SE0200312A patent/SE0200312D0/xx unknown
-
2003
- 2003-01-29 ES ES03703575T patent/ES2321180T3/es not_active Expired - Lifetime
- 2003-01-29 AT AT03703575T patent/ATE423552T1/de active
- 2003-01-29 PT PT08166881T patent/PT2036549E/pt unknown
- 2003-01-29 JP JP2003563536A patent/JP2005521663A/ja not_active Withdrawn
- 2003-01-29 US US10/502,685 patent/US7759328B2/en not_active Expired - Lifetime
- 2003-01-29 AU AU2003206289A patent/AU2003206289B2/en not_active Expired
- 2003-01-29 DE DE60326320T patent/DE60326320D1/de not_active Expired - Lifetime
- 2003-01-29 ES ES08166881T patent/ES2342509T3/es not_active Expired - Lifetime
- 2003-01-29 DK DK03703575T patent/DK1474117T3/da active
- 2003-01-29 NZ NZ534452A patent/NZ534452A/en not_active IP Right Cessation
- 2003-01-29 WO PCT/SE2003/000156 patent/WO2003063842A1/en not_active Ceased
- 2003-01-29 AT AT08166881T patent/ATE463241T1/de active
- 2003-01-29 KR KR1020047011787A patent/KR100947168B1/ko not_active Expired - Lifetime
- 2003-01-29 SI SI200331805T patent/SI2036549T1/sl unknown
- 2003-01-29 CA CA2474479A patent/CA2474479C/en not_active Expired - Lifetime
- 2003-01-29 DK DK08166881.6T patent/DK2036549T3/da active
- 2003-01-29 KR KR1020097024298A patent/KR20090125857A/ko not_active Ceased
- 2003-01-29 DE DE60332067T patent/DE60332067D1/de not_active Expired - Lifetime
- 2003-01-29 CN CNB038031221A patent/CN1287774C/zh not_active Expired - Lifetime
- 2003-01-29 PL PL372118A patent/PL211836B1/pl unknown
- 2003-01-29 EP EP03703575A patent/EP1474117B1/en not_active Revoked
- 2003-01-29 EP EP08166881A patent/EP2036549B1/en not_active Expired - Lifetime
- 2003-01-29 UA UA20040806416A patent/UA79445C2/uk unknown
- 2003-01-29 BR BR0307193-6A patent/BR0307193A/pt not_active Application Discontinuation
- 2003-01-29 SI SI200331563T patent/SI1474117T1/sl unknown
- 2003-01-29 RU RU2004122921/15A patent/RU2301673C2/ru active
- 2003-01-29 PT PT03703575T patent/PT1474117E/pt unknown
-
2004
- 2004-07-21 IS IS7360A patent/IS7360A/is unknown
- 2004-07-22 IL IL163160A patent/IL163160A/en active IP Right Grant
- 2004-07-27 CO CO04071996A patent/CO5611098A2/es not_active Application Discontinuation
- 2004-07-28 MX MXPA04007295A patent/MXPA04007295A/es active IP Right Grant
- 2004-07-29 ZA ZA2004/06086A patent/ZA200406086B/en unknown
- 2004-08-19 NO NO20043458A patent/NO337006B1/no not_active IP Right Cessation
-
2009
- 2009-04-29 CY CY20091100471T patent/CY1109030T1/el unknown
-
2010
- 2010-02-26 JP JP2010041992A patent/JP5259636B2/ja not_active Expired - Lifetime
- 2010-05-28 US US12/790,196 patent/US8143239B2/en not_active Expired - Fee Related
- 2010-06-14 CY CY20101100546T patent/CY1110081T1/el unknown
-
2012
- 2012-03-05 US US13/411,939 patent/US8575137B2/en not_active Expired - Fee Related
-
2013
- 2013-04-16 IS IS9028A patent/IS2960B/is unknown
- 2013-10-18 US US14/057,548 patent/US20140286878A1/en not_active Abandoned
-
2015
- 2015-03-02 US US14/635,550 patent/US20160022703A1/en not_active Abandoned
-
2017
- 2017-02-08 US US15/427,425 patent/US10166247B2/en not_active Expired - Lifetime
-
2018
- 2018-08-22 US US16/108,368 patent/US20190216828A1/en not_active Abandoned
-
2020
- 2020-03-27 US US16/832,590 patent/US11311558B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE423552T1 (de) | Zusammensetzung zur inhalation | |
| SI2042168T1 (sl) | Inhalacijska formulacija, ki obsega fenetanolaminske derivate, za zdravljenje respiratornih bolezni | |
| DE69526425D1 (de) | Verwendung von mometasone-furoat zur behandlung von luftweg- und lungenerkrankungen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| IL205320A0 (en) | Compositions comprising an electrochemically altered fluid and a therapeutic agent and use thereof for treating lung or respiratory diseases | |
| SG148194A1 (en) | Compositions for the treatment of affections of the oral cavity and upper respiratory tract | |
| CY1110369T1 (el) | Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη | |
| EA200500328A1 (ru) | Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| ATE306271T1 (de) | Kombination von loteprednol und beta2- adrenozeptor-agonisten und ihre verwendung durch inhalation zur behandlung von asthma bronchiale | |
| IL173370A0 (en) | Combination of an anticholinergic and asteroid and its use to treat respiratory disorders by inhalation | |
| IL165574A0 (en) | Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases | |
| DE60206391D1 (de) | Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen | |
| CN2698391Y (zh) | 鼻护 | |
| HK1099514A (en) | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma | |
| HU0203447D0 (en) | Use of polysaccharide-sulfuric acid-derivatives for preparing pharmaceutical composition effective for curing psoriasis and other skin diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8363 | Opposition against the patent |